Qualigen Therapeutics, Inc. - Common Stock (QLGN)
3.2700
-0.1350 (-3.96%)
Qualigen Therapeutics Inc is a biotechnology company focused on developing and commercializing innovative therapies and diagnostics for various medical conditions
Its primary mission is to enhance healthcare solutions through its proprietary technologies, particularly in the fields of oncology and infectious diseases. The company offers a range of products, including its advanced diagnostic platforms that aim to facilitate quicker and more accurate disease detection, as well as therapeutic candidates designed to improve treatment outcomes for patients facing serious health challenges. Through its cutting-edge research and development efforts, Qualigen seeks to contribute to the future of personalized medicine and improve the quality of life for patients worldwide.
Previous Close | 3.405 |
---|---|
Open | 3.360 |
Bid | 3.080 |
Ask | 3.400 |
Day's Range | 3.122 - 3.366 |
52 Week Range | 0.0751 - 5.144 |
Volume | 31,063 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 104,197 |